<DOC>
	<DOCNO>NCT01983111</DOCNO>
	<brief_summary>The purpose study compare efficacy safety buprenorphine transdermal system tramadol/acetaminophen .</brief_summary>
	<brief_title>Compare Efficacy Safety Norspan Tramadol/Acetaminophen With Prolonged Postoperative Pain ( PASSION )</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Tramadol</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Korean men woman age 20 year Presence pain associate spinal disease lumbar fusion 12 spinal segment ( 12 level lumbar fusion surgery ) Moderate severe pain NRS pain score â‰¥ 4 Visit 1 ( 14~90 day surgery , Baseline ) ( Amended 21Nov2013 ) Consent participate study voluntary signature inform consent form Women childbearing potential , except follow case : A partner vasectomized otherwise surgically sterile . Use 2 contraception method . Two method include combination doublebarrier contraception barrier contraception hormone contraception , appropriate barrier method follow : Diaphragm ( female contraceptive device ) , condom , intrauterine ( copper hormone ) , sponge spermicide . Hormonal contraceptive include commercially available product contain estrogen and/or progesterone . Pregnant breastfeed woman . Pregnant woman define woman fertilization late pregnancy positive result urine pregnancy test . History hypersensitivity buprenorphine , tramadol , APAP excipients , celecoxib Medical history asthma , acute rhinitis , nasal polyp , vascular edema urticaria allergic reaction aspirin nonsteroidal antiinflammatory drug ( NSAIDs , COX2 ) Hypersensitivity intolerance Domperidone Risk gastrointestinal irritation gastrointestinal bleeding , mechanical ileus perforation Genetic problem galactose intolerance , Lapp lactase deficiency glucosegalactose malabsorption Severely impaired respiratory function respiratory depression Current use monoamine oxidase ( MAO ) inhibitor medication history within 2 week prior study participation Convulsive disorder , head injury , shock , decrease level consciousness uncertain origin , intracranial lesion increase intracranial pressure severe hepatic impairment Biliary tract disorder Presence suspect drug abuse history Medical history opioid drug dependence Current use CNS inhibitor muscle relaxant may result dyspnea , hypotension , severe sedation coma use investigational product , opioid analgesic Use strong opioids , buprenorphine tramadol/APAP within 1 week prior study participation ( however , study participation allow PRN prescription PCA strong opioids ) Any condition represent contraindication application buprenorphine , tramadol/APAP celecoxib Major pain attributable spinal disease Anticancer therapy may affect pain assessment Clinically significant cardiovascular renal dysfunction Postoperative complication Symptoms acute pain lumbar fusion characteristic analgesic feature show rapidly change need analgesic Current use investigational product enrollment within 30 day administration investigational product</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>